GI
VIR icon

GAMMA Investing’s Vir Biotechnology VIR Stock Holding History

GAMMA Investing’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.2K Buy
5,120
+152
+3% +$1.45K ﹤0.01% 2269
2026
Q1 		$44.5K Buy
4,968
+2,531
+104% +$20.2K ﹤0.01% 2253
2025
Q4 		$14.7K Buy
2,437
+797
+49% +$4.75K ﹤0.01% 2787
2025
Q3 		$9.36K Buy
1,640
+304
+23% +$1.55K ﹤0.01% 2910
2025
Q2 		$6.73K Sell
1,336
-5,775
-81% -$31K ﹤0.01% 2996
2025
Q1 		$46.1K Buy
7,111
+5,972
+524% +$53.1K ﹤0.01% 1848
2024
Q4 		$8.36K Sell
1,139
-292
-20% -$2.3K ﹤0.01% 2707
2024
Q3 		$10.7K Sell
1,431
-1,427
-50% -$12.4K ﹤0.01% 2425
2024
Q2 		$25.4K Buy
2,858
+150
+6% +$1.44K ﹤0.01% 1687
2024
Q1 		$27.4K Buy
2,708
+1,934
+250% +$19.7K 0.01% 1429
2023
Q4 		$7.28K Buy
+774
New +$7.07K ﹤0.01% 2063

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

GAMMA Investing's VIR Position: Q2 2026 in Review

GAMMA Investing increased its Vir Biotechnology (VIR) stake by 3.1% in Q2 2026, buying an estimated $1.45K and bringing the position to 5,120 shares worth $52.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2269.

GAMMA Investing first reported a position in VIR in Q4 2023 and has held it in 11 quarters since. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • GAMMA Investing held 5,120 shares of Vir Biotechnology worth $52.2K as of Q2 2026.
  • GAMMA Investing bought 152 Vir Biotechnology shares in Q2 2026, an estimated $1.45K.
  • Vir Biotechnology made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2269 holding.
  • GAMMA Investing first reported a position in Vir Biotechnology in Q4 2023 and has held it in 11 quarters since.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.